Supreme Court Justice Ruth Bader Ginsburg was released from the hospital Tuesday following cancer surgery, CNN reported. Kathy Arberg, public information officer for the Supreme Court, confirmed in an email to CNN that the 85-year-old jurist was discharged from Memorial Sloan Kettering Cancer Center in New York and is recovering at home. Ginsburg had two…
Supreme Court Justice Ruth Bader Ginsburg is working from her hospital bed as she recovers from cancer surgery, The Guardian reported. Ginsburg is still at Memorial Sloan Kettering Cancer Center in New York, said Kathy Arberg, a spokeswoman for the court. It’s unclear when she will be discharged. The 85-year-old jurist had two cancerous growths…
Julia Louis-Dreyfus is a wildly talented actress who has won seven Emmy awards and seems like a genuinely great person. She is the only performer who starred on “Seinfeld” and is now more famous for acting in something that isn’t “Seinfeld.” And she has been so generous with her fans with news about her September…
Most Jewish women face the question at some point: To test, or not to test. It is widely understood that Ashkenazi women are uniquely at risk for breast and uterine cancers — a risk that boils down to a few genetic indicators. Now, the genetic testing behemoth 23andMe is offering a new, FDA-approved test for…
Cancer cells, by definition, are abnormal cells that divide with abandon and have the potential to spread throughout and wreak havoc on your vital organs and tissues. But what if you could tell those same troublesome cells to stop misbehaving? Israeli scientists think they’ve found a way to do just that. A group of researchers…
(JTA) — The mother of a 3-year-old with a rare form of cancer criticized Spirit Airlines for lacking compassion after a flight from Florida to California for an appointment with the boy’s surgeon took off without them. The Tallman family arrived at Fort Lauderdale-Hollywood International Airport in Delray Beach on Monday two hours early for…
NEW YORK (JTA) — A new study will provide free testing for three mutations that substantially increase the risk for developing breast, ovarian and prostate cancer among people with Eastern European Jewish ancestry. The BRCA Founder Outreach Study (BFOR), which was launched last week, will test 4,000 men and women in four U.S. cities —…
23andMe recently received FDA approval to inform customers of its popular mail-in DNA tests about their risk for breast cancer, the Atlantic reported. 23andMe is the first company to get federal approval for a direct-to-consumer genetic cancer risk test. The FDA sanctioned 23andMe’s request to tell customers whether they have mutations on the genes BRCA-1…
100% of profits support our journalism
